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ABSTRACT  
The cryopreservation of cells and tissue engineered constructs is determined by multiple factors, such as possible cellular 
damages due to mass and heat transfer during the freezing and thawing process. It is assumed that the utilization of 
cryobags improves the heat transfer during freezing and thawing and is therefore superior in comparison to currently 
applied cryovials and multiwell plates. Therefore, we have analysed the cryopreservation of cell-seeded electrospun 
polycaprolactone/polylactide scaffolds within cryobags. Additionally, the performance of four different cryoprotective 
agents was analysed, which included 10% (v/v) dimethyl sulfoxide and 10% (v/v) ethylene glycol as separately applied 
agents as well as their combination with 0.3 M sucrose. The samples were frozen in in-house made cryobags with a 
controlled rate freezer. The cell viability was analysed by fluorescence microscopy before freezing and after thawing. The 
results show, that the application of cryobags in combination with 10% (v/v) ethylene glycol can have a positive impact 
onto the cell viability. 
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INTRODUCTION 
In recent years, the development and analysis of tissue 
engineered constructs (TECs) has increased within 
regenerative medicine [1], as TECs hold the potential 
application as substitutes for the regeneration of tissue 
defects [2-4]. Especially the development of suitable 
scaffolds is of upmost importance. A desired cell type is 
seeded onto the scaffolds’ surface and proliferates in 
vitro. Finally, the scaffolds can be applied to the 
defective site [5]. Regarding this methodical approach, 
the electrospinning method is a widely utilized and 
versatile scaffold fabrication technique. Thereby a thin 
fibre is formed out of a polymeric solution due to the 
application of an electric field and is collected. 
Dependent upon the set process parameters, the fibre 
mats can be tailored [6-8]. 
However, a remaining challenge is the long-term storage 
of biological products. Currently, the frequently applied 
hypothermic preservation methods do not allow a 
sufficient long-term storage [9, 10]. Therefore, new 
preservation methods have to be evolved in order to 
ensure a sufficient availability of TECs. A possible 
alternative to overcome these limitations in storing 
duration of TECs is cryopreservation. This method 
enables the storage at sub-zero temperatures, thus 
reducing metabolic activity and increasing the shelf-life. 
It has to be noted though, that also this preservation 
method is influenced by various parameters [11, 12]. 
Due to the cryogenic conditions as well as due to 
multiple parameters, such as mass and heat transfer 
during freezing and thawing, cellular injury can occur 
[13, 14]. A possibility to enhance the heat transfer is the 
utilization of cryobags since they possess a comparably 
flatter structure. However, different cell types have 
already been cryopreserved within cryobags [15-19] but 
to the field of TECs this method is fairly new and the 
various influences of the preservation method onto the 
specimen have to be investigated further.  
Therefore, the aim of this study was to analyse the 
viability of cryopreserved cells, seeded onto electrospun 
scaffolds and stored within cryobags as well as the 
impact of different cryoprotective agents (CPAs). The 
results were compared to previous studies of our group, 
in which the cell-seeded TECs were cryopreserved 






Electrospinning and sample preparation  
The scaffolds were fabricated by electrospinning. 
Polycaprolactone (PCL, from Aldrich) with an average 
Mn of 80,000 and polylactic acid (PLLA, from 
Natureplast) with an average Mn of 150,000 were 
dissolved in 2.2.2-trifluoroethanol (TFE, from abcr) 
with a mass concentration ratio of 100:50 (mg ml-1: 
mg ml-1). The solution homogenized for 24 h before 
electrospinning.  
Electrospinning was performed in a horizontal 
orientation. The polymer solution was ejected through a 
metallic needle (0,8 mm inner diameter, from B. Braun) 
at an applied flow rate of 3 ml h-1 and a voltage of 15 kV 
with a spinning distance of 21 cm and a duration of 
100 min. The fibres where collected on a rotating drum 
collector at 220 rpm. 
Finally, the electrospun fibre mats were UV sterilized on 
each side for a duration of 15 min and punched into 
16 mm scaffolds.  
Cryopreservation 
SaOS-2 cells were utilized for the viability analysis. The 
cells were seeded onto the surface of the electrospun 
scaffolds at a density of 5×104 cells cm-2 and 
proliferated for 3 days under physiological conditions in 
an incubator before cryopreservation. Control samples 
were analysed before preservation. 
Prior to cryopreservation, the samples were loaded with 
different CPA-solutions (Table 1) at 4°C for 10 min, 
before being transferred into cryobags (ProfiCook) and 
cooled in a controlled rate freezer (Planer) at 1 K min-1 
to -100°C, then being plunged into liquid nitrogen and 
stored at -140°C in a cryogenic freezer (Fisher 
Scientific). Every cryobag contained four identical 
TECs and was frozen in our previously described “in-
air” method [20]. 
After low temperature storage the TECs were rapidly 
thawed in a water bath at 37°C for 15 s. The samples 
were placed in multiwell plates (TPP) containing warm 
culture medium and incubated for 5 min. The medium 
was refreshed and the samples were cultured for 24 h 
before the viability analysis. 
Cell viability analysis 
The cell viability was analysed by live-dead assay with 
a fluorescence microscope (Zeiss). Prior to staining, the 
samples were washed twice in 2 ml PBS before and after 
applying the staining solution. Calcein AM (Biotium) 
and Ethidium Homodimer-1 (Aldrich) served as 
fluorescence dyes. Images were taken in a z-stack mode 
and the cell viability was analysed with the ImageJ 
software (NIH). 
Table 1: Four different CPA solutions were prepared. 
Dimethyl sulfoxide (DMSO, from Roth) and ethylene 
glycol (EG, from Aldrich) with and without sucrose 
(Suc, from Aldrich). All solutions contained 20% fetal 
bovine serum (FBS, from Biochrom) and Dulbecco's 
Modified Eagle Medium (DMEM, from Biochrom). 
Values in percent are v/v. 
Solution DMSO EG Suc 
DMSO 10% - - 
DMSO+Suc 10% - 0.3 M 
EG - 10% - 
EG+Suc - 10% 0.3 M 
 
Data analysis and statistics 
All data were collected from four individual 




Cell viability analysis 
Two different morphologies of attached cells were 
present on the TECs surface. The dominant cell 
morphology had a round shape, but also stretched cells 
were visible. Additionally, the cells were also partially 
aligned in fibre orientation. It was discovered, that the 
cell morphology was not affected by the 
cryopreservation process. 
On day 3, a viability of 97% ± 2% could be obtained for 
the cultivated cell-seeded TECs prior to 
cryopreservation, serving as a control.  
After the cryopreservation and recultivation, the post-
thaw cell viability was influenced by the applied CPA-
solution. In this study, the highest cell viability with a 
mean value of 80% ± 11% could be obtained with 10% 
(v/v) EG as well as its combination with 0,3 M sucrose 
(79% ± 7%), respectively. In comparison, the 
application of 10% (v/v) DMSO yielded in a post-thaw 
viability of 77% ± 6%. Combining DMSO with sucrose 
lead to a viability of 78% ± 7%.  
It has to be noted, that the post-thaw viability can be 
influenced by rupture of the cryobags during the 
thawing procedure and will yield in a reduced viability.  
Generally, the trend of viability also corresponds with 




post-thaw cell number was present for a CPA-solution 
containing 10% (v/v) EG as well as its combination with 
sucrose.  
Figure 1: Post-thaw viability. n=64 (1n=44, 2n=60) 
 
Figure 2: Representative live-dead images. Control 




Within the field of cryobiology, the application of CPAs 
is of vital importance in order to achieve a sufficient 
post-thaw viability. In this study, all analysed CPA-
solutions enabled a viability of >70%. Furthermore, the 
highest viability was obtained for solutions containing 
10% (v/v) EG. Since the applied concentrations of 
DMSO and EG are identical and the membrane 
permeation is known to dependent upon the molecular 
weight of the CPA [21], this could provide an 
explanation for the obtained viability. Therefore, EG 
could provide a suitable alternative to DMSO, which is 
known to induce a toxic effect above 4°C [22]. 
However, possible toxic effects of EG on the cells 
should still be elaborated in future. Furthermore, sucrose 
only had a subdominant effect on the viability. This 
correlates with previous findings [23]. It is also known, 
that the diffusion rate of sucrose into tissue is lower than 
other CPAs such as DMSO [24].  
The utilization of cryobags holds a promising approach 
to increase the post-thaw cell viability. Compared to 
current cryopreservation methods in cryovials or in 
multiwell plates, the cryobags possess the advantage of 
being customizable to the individual volume and 
geometry of each sample. It has to be noted though, that 
the cryobag material can be potentially susceptible to 
rupture during the thawing process and can cause cell 
loss, as discovered in our study. The material failure has 
also been previously described by other authors [25, 26]. 
In this current study, a possibility to overcome this 
limitation was achieved be thawing in a warm PBS bath. 
Previously our group also cryopreserved TECs within 
multiwell plates. A comparison indicates that a higher 
post-thaw viability could be obtained within the 
cryobags (data not shown). Therefore, cryobags seem to 
improve the heat transfer and thus enable an enhanced 
cryopreservation outcome.  
 
CONCLUSIONS 
The current cryopreservation methods enable the long-
term storage of cell-seeded TECs. In view of the utilized 
CPAs, 10% (v/v) EG offers a suitable alternative to the 
commonly applied but more toxic DMSO. Also, the 
application of sucrose can have a beneficial impact onto 
the cell viability. Regarding the storage method of 
TECs, cryobags improve the post-thaw cell viability 
compared to multiwell plates, and therefore represent an 
alternative preservation method.  
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